MMED News
Archived Headlines
- Medtronic diabetes business carve-out MiniMed sets terms for $742 million IPO 02/24/26
- US IPO Week Ahead: Asthma biotech set to close out February IPO market 02/20/26
- US IPO Week Ahead: Markets set for a quiet week after year’s first sizable IPO 01/09/26
- US IPO Week Ahead: Aktis Oncology set to open 2026 IPO Market 01/02/26
- US IPO Weekly Recap: Medline and Andersen soar ahead of Christmas holiday 12/19/25
See more
Updated: Renaissance Capital's 1Q 2026 US IPO Market Review
Volatile Markets Delay the Great IPO Rebound Again Surging volatility grounded the IPO party before it took off, as markets grappled with a tech sell-off, more tariff turmoil, private credit woes, and war in the Middle East in the first quarter of 2026. After ...read more
US IPO Weekly Recap: Diabetes medtech MiniMed slides 8% in a quiet week for IPOs
The March IPO market started off with a quiet week. MiniMed Group (MMED) completed the week’s sole IPO, joined by two SPACs, and just one small issuer joined the pipeline. Medtronic carve-out MiniMed priced below the range to raise $560 million at a $5....read more
Medtronic diabetes business carve-out MiniMed prices IPO at $20, below the range
MiniMed Group, a carve-out of Medtronic's diabetes management devices and technology business, raised $560 million by offering 28 million shares at $20, below the range of $25 to $28. At the pricing, the company commands a market cap of $5.6 billion. Being...read more
US IPO Week Ahead: Medtronic carve-out MiniMed to kick-off March calendar
One large IPO is currently scheduled in the week ahead, although some smaller issuers may join the calendar throughout the week. Medtronic diabetes business carve-out MiniMed (MMED) plans to raise $742 million at a $7.4 billion market cap. MiniMed focuses...read more